268 related articles for article (PubMed ID: 38560428)
1. Systematic review of metabolomic alterations in ulcerative colitis: unveiling key metabolic signatures and pathways.
Liu M; Guo S; Wang L
Therap Adv Gastroenterol; 2024; 17():17562848241239580. PubMed ID: 38560428
[TBL] [Abstract][Full Text] [Related]
2. Alterations in Lipid, Amino Acid, and Energy Metabolism Distinguish Crohn's Disease from Ulcerative Colitis and Control Subjects by Serum Metabolomic Profiling.
Scoville EA; Allaman MM; Brown CT; Motley AK; Horst SN; Williams CS; Koyama T; Zhao Z; Adams DW; Beaulieu DB; Schwartz DA; Wilson KT; Coburn LA
Metabolomics; 2018 Jan; 14(1):17. PubMed ID: 29681789
[TBL] [Abstract][Full Text] [Related]
3. Evidence for the butyrate metabolism as key pathway improving ulcerative colitis in both pediatric and adult patients.
Zhou Z; Cao J; Liu X; Li M
Bioengineered; 2021 Dec; 12(1):8309-8324. PubMed ID: 34592880
[TBL] [Abstract][Full Text] [Related]
4. Identification of shared gene signatures and molecular mechanisms between chronic kidney disease and ulcerative colitis.
Liang Z; Hu X; Lin R; Tang Z; Ye Z; Mao R; Chen W; Zhou Y
Front Immunol; 2023; 14():1078310. PubMed ID: 36860851
[TBL] [Abstract][Full Text] [Related]
5. Mucosal Metabolomic Profiling and Pathway Analysis Reveal the Metabolic Signature of Ulcerative Colitis.
Diab J; Hansen T; Goll R; Stenlund H; Jensen E; Moritz T; Florholmen J; Forsdahl G
Metabolites; 2019 Nov; 9(12):. PubMed ID: 31783598
[TBL] [Abstract][Full Text] [Related]
6. The Underlying Changes in Serum Metabolic Profiles and Efficacy Prediction in Patients with Extensive Ulcerative Colitis Undergoing Fecal Microbiota Transplantation.
Wu X; Li P; Wang W; Xu J; Ai R; Wen Q; Cui B; Zhang F
Nutrients; 2023 Jul; 15(15):. PubMed ID: 37571277
[TBL] [Abstract][Full Text] [Related]
7. Identification of key genes and biological processes contributing to colitis associated dysplasia in ulcerative colitis.
Zhang D; Yan P; Han T; Cheng X; Li J
PeerJ; 2021; 9():e11321. PubMed ID: 33987007
[TBL] [Abstract][Full Text] [Related]
8. Unveiling the key genes, environmental toxins, and drug exposures in modulating the severity of ulcerative colitis: a comprehensive analysis.
Wang Y; Zhuang H; Jiang XH; Zou RH; Wang HY; Fan ZN
Front Immunol; 2023; 14():1162458. PubMed ID: 37539055
[TBL] [Abstract][Full Text] [Related]
9. Integrated network pharmacology and metabolomics reveal the mechanisms of Jasminum elongatum in anti-ulcerative colitis.
Qiu J; Xiao G; Yang M; Huang X; Cai D; Xie C; Chen Z; Bi X; Xu A
Sci Rep; 2023 Dec; 13(1):22449. PubMed ID: 38105335
[TBL] [Abstract][Full Text] [Related]
10. Compound Sophorae Decoction: treating ulcerative colitis by affecting multiple metabolic pathways.
Hong ZC; Cai Q; Wu HZ; Yang YF; Fan H; Duan XY
Chin J Nat Med; 2021 Apr; 19(4):267-283. PubMed ID: 33875167
[TBL] [Abstract][Full Text] [Related]
11. Unfractionated or low-molecular weight heparin for induction of remission in ulcerative colitis.
Chande N; McDonald JW; Macdonald JK
Cochrane Database Syst Rev; 2008 Apr; (2):CD006774. PubMed ID: 18425969
[TBL] [Abstract][Full Text] [Related]
12. Coptidis Rhizoma processed with Evodia Rutaecarpa improves the effect on ulcerative colitis by increasing intestinal energy metabolites alpha-ketoglutarate and Lactobacillus reuteri.
Luo ZY; Hu YX; Qiu CW; Chen WC; Li L; Chen FL; Liu CS
Phytomedicine; 2023 Dec; 121():155115. PubMed ID: 37801896
[TBL] [Abstract][Full Text] [Related]
13. Mechanism of Huang-lian-Jie-du decoction and its effective fraction in alleviating acute ulcerative colitis in mice: Regulating arachidonic acid metabolism and glycerophospholipid metabolism.
Yuan Z; Yang L; Zhang X; Ji P; Hua Y; Wei Y
J Ethnopharmacol; 2020 Sep; 259():112872. PubMed ID: 32417423
[TBL] [Abstract][Full Text] [Related]
14. Unfractionated or low-molecular weight heparin for induction of remission in ulcerative colitis.
Chande N; McDonald JW; Macdonald JK; Wang JJ
Cochrane Database Syst Rev; 2010 Oct; (10):CD006774. PubMed ID: 20927749
[TBL] [Abstract][Full Text] [Related]
15. Integrated study of metabolomics and gut metabolic activity from ulcerative colitis to colorectal cancer: The combined action of disordered gut microbiota and linoleic acid metabolic pathway might fuel cancer.
Tang Q; Cang S; Jiao J; Rong W; Xu H; Bi K; Li Q; Liu R
J Chromatogr A; 2020 Oct; 1629():461503. PubMed ID: 32858455
[TBL] [Abstract][Full Text] [Related]
16. An inulin-type fructan CP-A from
Zhou J; Wang J; Li D; Zhang Z; Wang C; Zhang X; Xu X; Gao J
Am J Physiol Gastrointest Liver Physiol; 2024 Mar; 326(3):G216-G227. PubMed ID: 38193197
[TBL] [Abstract][Full Text] [Related]
17. Alterations in metabolome and microbiome signatures provide clues to the role of antimicrobial peptide KT2 in ulcerative colitis.
Nan Q; Ye Y; Tao Y; Jiang X; Miao Y; Jia J; Miao J
Front Microbiol; 2023; 14():1027658. PubMed ID: 36846795
[TBL] [Abstract][Full Text] [Related]
18. Differential analysis of intestinal microbiota and metabolites in mice with dextran sulfate sodium-induced colitis.
Wang JL; Han X; Li JX; Shi R; Liu LL; Wang K; Liao YT; Jiang H; Zhang Y; Hu JC; Zhang LM; Shi L
World J Gastroenterol; 2022 Nov; 28(43):6109-6130. PubMed ID: 36483152
[TBL] [Abstract][Full Text] [Related]
19. Identification of differentially expressed genes in ulcerative colitis and verification in a colitis mouse model by bioinformatics analyses.
Shi L; Han X; Li JX; Liao YT; Kou FS; Wang ZB; Shi R; Zhao XJ; Sun ZM; Hao Y
World J Gastroenterol; 2020 Oct; 26(39):5983-5996. PubMed ID: 33132649
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]